BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT05161325 updates: 1. completion date: 2026-06-01 → 2027-03-31 2. primary completion date: 2025-12-31 → 2026-12-31
Clinical trial NCT05161325 updates: 1. completion date: 2026-06-01 → 2027-03-31 2. primary completion date: 2025-12-31 → 2026-12-31
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical